The invention is relevant to chemistry of organic compounds, pharmacology and medicine, and is related to treatment and/or prevention of a disease or condition, associated with over expressed or dysregulated glutamine-dependent asparagine synthetase, using a new family of chemical compounds having the ability to inhibit asparagine synthetase (ASMS). New chemical compounds with high inhibitory activity against asparagine synthase and promising for use in therapy. This invention also covers pharmaceutical compositions containing therapeutically effective amount of compound according to the invention and method of treatment and/or prevention of a disease or condition, associated with over-expressed or dysregulated glutamine dependent asparagine synthetase.
这项发明涉及到有机化合物的
化学、药理学和医学,与治疗和/或预防与过度表达或失调的谷
氨酰胺依赖性
天冬氨酸合成酶相关的疾病或症状有关,使用具有抑制
天冬氨酸合成酶(ASMS)能力的新一类
化学化合物。具有高抑制活性的新
化学化合物对于
天冬氨酸合成酶具有潜在治疗用途。该发明还涵盖含有根据该发明的化合物的治疗有效量的药物组合物,以及与过度表达或失调的谷
氨酰胺依赖性
天冬氨酸合成酶相关的疾病或症状的治疗和/或预防方法。